Skip to main content
Top
Published in: American Journal of Clinical Dermatology 3/2001

01-06-2001 | Pharmacovigilance

Cutaneous Drug Reaction Case Reports

From the World Literature

Published in: American Journal of Clinical Dermatology | Issue 3/2001

Login to get access

Excerpt

Skin disorders are the most common adverse reactions attributed to drugs. Any skin disorder can be imitated, induced or aggravated by drugs. To help you keep up-to-date with the very latest skin reactions occurring with both new and established drugs, this section of the journal brings you information selected from the adverse drug reaction alerting service Reactions Weekly 1. The following case reports are selected from the very latest to be published in the world dermatology literature. Any claim of a first report has been verified by a search of AdisBase (a proprietary database of Adis International) and Medline. Each case report is assessed for seriousness using the FDA MedWatch definition of serious (patient outcome is: death; life-threatening; hospitalization; disability; congenital anomaly; or requires intervention to prevent permanent impairment or damage). …
Footnotes
1
Reactions Weekly is the complete drug safety alerting service and summarizes information selected from over 1800 biomedical journals. This newsletter is produced by Adis International and is available in a variety of formats. Please contact your nearest Adis office for subscription details.
 
Literature
go back to reference Kick G., Przybilla B. Delayed prick test reaction identifies amoxicillin as elicitor of baboon syndrome. Contact Dermatitis 2000 Dec; 43: 366–367PubMed Kick G., Przybilla B. Delayed prick test reaction identifies amoxicillin as elicitor of baboon syndrome. Contact Dermatitis 2000 Dec; 43: 366–367PubMed
go back to reference de Thier F., Blondeel A., Song M. Acute generalized exanthematous pustulosis induced by amoxycillin with clavulanate. Contact Dermatitis 2001; 44: 114–115PubMedCrossRef de Thier F., Blondeel A., Song M. Acute generalized exanthematous pustulosis induced by amoxycillin with clavulanate. Contact Dermatitis 2001; 44: 114–115PubMedCrossRef
go back to reference Bachmeyer C., Cordier F., Blum L., et al. Multiple eruptive dermatofibromas after highly active antiretroviral therapy. Br J Dermatol 2000 Dec; 143: 1336–1337PubMedCrossRef Bachmeyer C., Cordier F., Blum L., et al. Multiple eruptive dermatofibromas after highly active antiretroviral therapy. Br J Dermatol 2000 Dec; 143: 1336–1337PubMedCrossRef
go back to reference Sakakibara T., Hata M., Numano K., et al. Fixed-drug eruption caused by allylisopropylacetylurea. Contact Dermatitis 2001 Mar; 44: 189–190PubMedCrossRef Sakakibara T., Hata M., Numano K., et al. Fixed-drug eruption caused by allylisopropylacetylurea. Contact Dermatitis 2001 Mar; 44: 189–190PubMedCrossRef
go back to reference Lauerma A.I., Koivuluhta M., Alenius H. Recalcitrant allergic contact dermatitis from azathioprine tablets. Contact Dermatitis 2001 Feb; 44: 129PubMedCrossRef Lauerma A.I., Koivuluhta M., Alenius H. Recalcitrant allergic contact dermatitis from azathioprine tablets. Contact Dermatitis 2001 Feb; 44: 129PubMedCrossRef
go back to reference Austin A.S., Spiller R.C. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review. Eur J Gastroenterol Hepatol 2001 Feb; 13: 193–194PubMedCrossRef Austin A.S., Spiller R.C. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review. Eur J Gastroenterol Hepatol 2001 Feb; 13: 193–194PubMedCrossRef
go back to reference Tani A., Miyoshi H., Kanzaki T., Allergic contact dermatitis due to beclometasone dipropionate in an inhalant for asthma. Contact Dermatitis 2000 Dec; 43: 363PubMed Tani A., Miyoshi H., Kanzaki T., Allergic contact dermatitis due to beclometasone dipropionate in an inhalant for asthma. Contact Dermatitis 2000 Dec; 43: 363PubMed
go back to reference Roos T.C., Merk H.F. Allergic contact dermatitis from benzocaine ointment during treatment of herpes zoster. Contact Dermatitis 2001; 44: 104PubMedCrossRef Roos T.C., Merk H.F. Allergic contact dermatitis from benzocaine ointment during treatment of herpes zoster. Contact Dermatitis 2001; 44: 104PubMedCrossRef
go back to reference Tanaka S., Otsuki T., Matsumoto Y., et al. Allergic contact dermatitis from enoxolone. Contact Dermatitis 2001 Mar; 44: 192PubMedCrossRef Tanaka S., Otsuki T., Matsumoto Y., et al. Allergic contact dermatitis from enoxolone. Contact Dermatitis 2001 Mar; 44: 192PubMedCrossRef
go back to reference Weber F., Barbaud A., Reichert-Penetrat S., et al. Unusual clinical presentation in a case of contact dermatitis due to corticosteroids diagnosed by ROAT. Contact Dermatitis 2001; 44: 105–106PubMedCrossRef Weber F., Barbaud A., Reichert-Penetrat S., et al. Unusual clinical presentation in a case of contact dermatitis due to corticosteroids diagnosed by ROAT. Contact Dermatitis 2001; 44: 105–106PubMedCrossRef
go back to reference Poon E., Fewings J.M. Generalized eczematous reaction to budesonide in a nasal spray with cross-reactivity to triamcinolone. Aust J Dermatol 2001 Feb; 42: 36–37CrossRef Poon E., Fewings J.M. Generalized eczematous reaction to budesonide in a nasal spray with cross-reactivity to triamcinolone. Aust J Dermatol 2001 Feb; 42: 36–37CrossRef
go back to reference Kawada A., Aragane Y., Maeda A., et al. Drug eruption induced by cefcapene pivoxil hydrochloride. Contact Dermatitis 2001 Mar; 44: 197PubMedCrossRef Kawada A., Aragane Y., Maeda A., et al. Drug eruption induced by cefcapene pivoxil hydrochloride. Contact Dermatitis 2001 Mar; 44: 197PubMedCrossRef
go back to reference Kränke B., Kern T. Multilocalized fixed drug eruption to the antihistamine cetirizine. J Allergy Clin Immunol 2000 Nov; 106: 988PubMedCrossRef Kränke B., Kern T. Multilocalized fixed drug eruption to the antihistamine cetirizine. J Allergy Clin Immunol 2000 Nov; 106: 988PubMedCrossRef
go back to reference Calista D., Schianchi S., Morri M. Urticaria induced by cetirizine. Br J Dermatol 2001 Jan; 144: 196PubMed Calista D., Schianchi S., Morri M. Urticaria induced by cetirizine. Br J Dermatol 2001 Jan; 144: 196PubMed
go back to reference Agarwal S., Berth-Jones J. A contact dermatitis reaction to clobetasol propionate cream associated with resolution of recalcitrant, generalized granuloma annulare. J Dermatol Treat 2000 Dec; 11: 279–282CrossRef Agarwal S., Berth-Jones J. A contact dermatitis reaction to clobetasol propionate cream associated with resolution of recalcitrant, generalized granuloma annulare. J Dermatol Treat 2000 Dec; 11: 279–282CrossRef
go back to reference Estrada J.L., Alvarez Puebla M.J., Ortiz de Urbina J.J., et al. Generalized eczema due to codeine. Contact Dermatitis 2001 Mar; 44: 185PubMedCrossRef Estrada J.L., Alvarez Puebla M.J., Ortiz de Urbina J.J., et al. Generalized eczema due to codeine. Contact Dermatitis 2001 Mar; 44: 185PubMedCrossRef
go back to reference Carnero L., Silvestre J.F., Guijarro J., Albares M.P., Botella R. Nuchal acne keloidalis associated with cyclosporin. Br J Dermatol 2001 Feb; 144: 429–430PubMedCrossRef Carnero L., Silvestre J.F., Guijarro J., Albares M.P., Botella R. Nuchal acne keloidalis associated with cyclosporin. Br J Dermatol 2001 Feb; 144: 429–430PubMedCrossRef
go back to reference Garcia-Bravo B., Repiso J.B., Camacho F. Systemic contact dermatitis due to deflazacort. Contact Dermatitis 2000 Dec; 43: 359–360PubMedCrossRef Garcia-Bravo B., Repiso J.B., Camacho F. Systemic contact dermatitis due to deflazacort. Contact Dermatitis 2000 Dec; 43: 359–360PubMedCrossRef
go back to reference Sánchez-Pérez J., López M.P., Moreno de Vega Haro M.J., et al. Allergic contact dermatitis from gentamicin in eyedrops, with cross-reactivity to kanamycin but not neomycin. Contact Dermatitis 2001 Jan; 44: 54PubMedCrossRef Sánchez-Pérez J., López M.P., Moreno de Vega Haro M.J., et al. Allergic contact dermatitis from gentamicin in eyedrops, with cross-reactivity to kanamycin but not neomycin. Contact Dermatitis 2001 Jan; 44: 54PubMedCrossRef
go back to reference Vilaplana J., Romaguera C. Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor. Contact Dermatitis 2001 Jan; 44: 47–48PubMedCrossRef Vilaplana J., Romaguera C. Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor. Contact Dermatitis 2001 Jan; 44: 47–48PubMedCrossRef
go back to reference Umebayashi Y., Ito S. Allergic contact dermatitis due to both lanoconazole and neticonazole ointments. Contact Dermatitis 2001 Jan; 44: 48–49PubMedCrossRef Umebayashi Y., Ito S. Allergic contact dermatitis due to both lanoconazole and neticonazole ointments. Contact Dermatitis 2001 Jan; 44: 48–49PubMedCrossRef
go back to reference Francis G.J., Silverman A.R., Saleh O., et al. Follicular mycosis fungoides associated with lithium. J Am Acad Dermatol 2001 Feb; 44: 308–309PubMedCrossRef Francis G.J., Silverman A.R., Saleh O., et al. Follicular mycosis fungoides associated with lithium. J Am Acad Dermatol 2001 Feb; 44: 308–309PubMedCrossRef
go back to reference Clark S.M., Lanigan S.W. Acute necrotic skin reaction to intramuscular Depo-Provera. Br J Dermatol 2000 Dec; 143: 1356–1357PubMedCrossRef Clark S.M., Lanigan S.W. Acute necrotic skin reaction to intramuscular Depo-Provera. Br J Dermatol 2000 Dec; 143: 1356–1357PubMedCrossRef
go back to reference Gastaminza G., Anda M., Audicana M.T., et al. Fixed-drug eruption due to metronidazole with positive topical provocation. Contact Dermatitis 2001 Jan; 44: 36PubMedCrossRef Gastaminza G., Anda M., Audicana M.T., et al. Fixed-drug eruption due to metronidazole with positive topical provocation. Contact Dermatitis 2001 Jan; 44: 36PubMedCrossRef
go back to reference Rault R. Mycophenolate-associated onycholysis. Ann Intern Med 2000 Dec 5; 133: 921–922PubMed Rault R. Mycophenolate-associated onycholysis. Ann Intern Med 2000 Dec 5; 133: 921–922PubMed
go back to reference Bernand S., Scheidegger E.P., Dummer R., et al. Multifocal fixed drug eruption to paracetamol, tropisetron and ondansetron induced by interleukin 2. Dermatology 2000; 201: 184–150CrossRef Bernand S., Scheidegger E.P., Dummer R., et al. Multifocal fixed drug eruption to paracetamol, tropisetron and ondansetron induced by interleukin 2. Dermatology 2000; 201: 184–150CrossRef
go back to reference Blaschke V., Fuchs T. Periorbital allergic contact dermatitis from oxybuprocaine. Contact Dermatitis 2001 March; 44: 198PubMedCrossRef Blaschke V., Fuchs T. Periorbital allergic contact dermatitis from oxybuprocaine. Contact Dermatitis 2001 March; 44: 198PubMedCrossRef
go back to reference Mermershtain W., Cohen A.D., Geffen D.B., et al. Cutaneous photosensitivity associated with abberations in the heme biosynthetic pathway induced by taxanes and trastuzumab: a report of 3 cases of metastatic breast cancer. Ann Oncol 2000; 11 (Suppl. 4): 28 Mermershtain W., Cohen A.D., Geffen D.B., et al. Cutaneous photosensitivity associated with abberations in the heme biosynthetic pathway induced by taxanes and trastuzumab: a report of 3 cases of metastatic breast cancer. Ann Oncol 2000; 11 (Suppl. 4): 28
go back to reference McMillen R., Duvic M. Alopecia areata occurring in sisters after administration of rifampicin. J Am Acad Dermatol 2001 Jan; 44: 142–143PubMedCrossRef McMillen R., Duvic M. Alopecia areata occurring in sisters after administration of rifampicin. J Am Acad Dermatol 2001 Jan; 44: 142–143PubMedCrossRef
go back to reference Martín García C., Carmena R., García R., et al. Fixed drug eruption from ticlopidine, with positive lesional patch test. Contact Dermatitis 2001 Jan; 44: 40–41CrossRef Martín García C., Carmena R., García R., et al. Fixed drug eruption from ticlopidine, with positive lesional patch test. Contact Dermatitis 2001 Jan; 44: 40–41CrossRef
Metadata
Title
Cutaneous Drug Reaction Case Reports
From the World Literature
Publication date
01-06-2001
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 3/2001
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200102030-00008

Other articles of this Issue 3/2001

American Journal of Clinical Dermatology 3/2001 Go to the issue

Adis New Drug Profile

Topical Eflornithine

Adis New Drug Profile

Topical Eflornithine

Review Article

Vitiligo

Adis New Drug Profile

Topical Eflornithine